Home › This Biotech ETF Has Thus Far Delivered On Its Potential
 

Keywords :   


This Biotech ETF Has Thus Far Delivered On Its Potential

2015-09-28 21:37:26| Biotech - Topix.net

The ALPS Medical Breakthroughs ETF - a fund focused on companies in late stage clinical trials - has jumped over 20% YTD, far outperforming small cap & biotech counterparts. The fund's managers have demonstrated a solid albeit short track record over the ETF's nine month history outperforming small cap, biotech and pharma indices.

Tags: its potential delivered biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
More »